U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 24F-2
Annual Notice of Securities Sold
Pursuant to Rule 24f-2
1. Name and address of issuer:
Metropolitan Series Fund, Inc.
c/o Metropolitan Life Insurance Company
One Madison Avenue, New York, New York, 10010-3690
2. Name of each series or class of funds for which this notice is filed:
State Street Research Growth Portfolio, State Street Research Income
Portfolio, State Street Research Money Market Portfolio, State Street
Research Diversified Portfolio, State Street Research Aggressive
Growth Portfolio, MetLife Stock Index Portfolio, Santander International
Stock Portfolio, Loomis Sayles High Yield Bond Portfolio, Janus Mid Cap
Portfolio, T. Rowe Price Small Cap Growth Portfolio, Scudder Global
Equity Portfolio, Harris Oakmark Large Cap Value Portfolio,
Neuberger Berman Partners Mid Cap Value Portfolio, T. Rowe Price Large
Cap Growth Portfolio, Lehman Brothers Aggregate Bond Index Portfolio,
Morgan Stanley EAFE Index Portfolio, Russell 2000 Index Portfolio.
3. Investment Company Act File Number: 811-3618
Securities Act File Number: 2-80751
4. Last day of fiscal year for which this notice is filed: December 31,1999
5. Check box if this notice is being filed more than 180 days after the close
of the issuer's fiscal year for purposes of reporting securities sold after
the close of the fiscal year but before termination of the issuer's 24f-2
declaration:
[ ]
6. Date of termination of issuer's declaration under rule 24f-2(a) (1), If
applicable (see Instruction A.6):
n/a
7. Number and amount of securities of the same class or series which had been
registered under the Securities Act of 1933 other than pursuant to rule
24f-2 in a prior fiscal year, which remained unsold at the beginning of
the fiscal year.
none
8. Number and amount of securities registered during the fiscal year other
than pursuant to rule 24f-2:
none
9. Number and aggregate sale price of securities sold during the fiscal year:
Number of securities sold: -199,826
**Aggregate sale price of securities sold: $62,782,876.55
10. Number and aggregate sale price of securities sold during the fiscal year
in reliance upon registration pursuant to rule 24f-2:
Number of securities sold: -199,826
**Aggregate sale price of securities sold: $62,782,876.55
11. Number and aggregate sale price of securities issued during the fiscal
year in connection with dividend reinvestment plans, if applicable (see
Instruction B.7):
Number of Securities issued : 1,035,376
**Aggregate sale price of securities issued : $26,874,216.76
12. Calculation of registration fee:
(i) Aggregate sale price of securities sold during the fiscal
year in reliance on rule 24f-2 (from Item 10): $62,782,876.55
(ii) Aggregate price of shares issued in connection with dividend
reinvestment plans (from Item 11,if applicable): + $26,874,216.76
(iii) Aggregate price of shares redeemed or repurchased
during the fiscal year (if applicable): - $86,647,255.77
(iv) Aggregate price of shares redeemed or repurchased and
previously applied as a reduction to filing fees
pursuant to rule 24e-2 (if applicable): n/a
(v) Net aggregate price of securities sold and issued during the fiscal
year in reliance on rule 24f-2 [line (i), plus line (ii), less line
(iii), plus line (iv)]
(if applicable): $3,009,837.54
(vi) Multiplier prescribed by Section 6(b) of the Securities
Act of 1933 or other applicable law or regulation (see
instruction C.6): x .000264
(vii) Fee due [line (i) or line (v) multiplied by line
(vi)]: $794.60
==================
13. Check box if fees are being remitted to the Commission's lockbox
depository as described in section 3a of the Commission's Rules of
Informal and Other Procedures (17 CFR 202.3a).
[x]
Date of mailing or wire transfer of filing fees to the Commission's
lockbox depository:
03/30/2000
Metropolitan Series Fund
Rule 24f-2; For the twelve months ending December 31,1999
Registration Statement File No. 2-80751 and File No. 811-3618
SIGNATURE
This report has been signed below by the following person on behalf
of the issuer and in the capacity and on the date indicated.
By (Signature and Title)*
/s/ Christopher P. Nicholas
Christopher P. Nicholas
President
Metropolitan Series Fund, Inc.
Date: March 30,2000
*Please print the name and title of the signing officer below the signature.
** Based on shares sold for MetLife Separate Account F which is exempt
from registration under the Securities Act of 1933.
